TAMPA BAY, Fla. – (May 6, 2013) – May marks the recognition of National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups mark this month with increased efforts to raise awareness of brain tumors and educate the public on symptoms and treatment options.
The Central Brain Tumor Registry estimates 66,290 new cases of primary non–malignant and malignant brain and central nervous system tumors are diagnosed in the United States annually. What patients may not know is that a large percentage of those diagnoses will be from metastatic tumors, tumors that develop from cancer cells that have spread from another part of the body.
And many people may not know there are more than 120 different types of brain tumors, and not all are necessarily fatal. Brain tumors often create increased pressure in the skull, known as intracranial hypertension. This can lead to, among other conditions, headaches, vomiting, vision problems and altered states of consciousness.
Brain tumors can be treated with surgery, radiation therapy, chemotherapy or a mixture of these therapies, which can slow the growth of tumors. However, for some patients, stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose, precisely targeted radiation, is also a leading option due to its increased accuracy and shorter treatment times.
CyberKnife is a robotic stereotactic radiosurgery system that treats cancerous and benign tumors in the brain by delivering targeted radiation beams directly to a tumor, minimizing damage to surrounding healthy tissue. Treatment is complete in one to five treatment sessions, and patients are allowed to go home immediately after each procedure to resume normal activities. Possible side effects include fatigue, but are usually minor and temporary. For patients with inoperable or surgically complex tumors, or those who seek an alternative to conventional surgery or radiation therapy, CyberKnife can be an important treatment option. Because treatment with CyberKnife does not require incisions or anesthesia, there is also less risk for complications than conventional surgery.
In addition to treating malignant and benign brain tumors, as well as brain metastases, CyberKnife Centers of Tampa Bay treats tumors of the lung, prostate, kidney, liver, spine, pancreas and eye.
CyberKnife provides these tips for those who have undergone cancer treatments to keep their mind sharp:
About CyberKnife Centers of Tampa Bay:
CyberKnife Centers of Tampa Bay was founded in 2008 when a group of radiation oncologists with extensive backgrounds and a combined 45 years of radiosurgical experience opened the first CyberKnife Center in Tampa Bay, located on the campus of Town and Country Hospital. Drawing on their experience with CyberKnife centers in Miami, Palm Beach and Naples and their expertise with other forms of radiosurgery, the group introduced this exciting new technology to Central Florida. CyberKnife Centers of Tampa Bay is owned and operated by Tampa Bay Radiosurgery Associates, LLC. With two freestanding facilities located in Tampa and Brandon, the staff at the outpatient centers is dedicated to providing image-guided radiosurgical treatments while understanding and upholding a standard of comfort for patients undergoing treatment. For more information visit www.CyberKnifeTampaBay.org.